This morning, St. Boniface Hospital Foundation announced the Grand Prize winner of the 2025 Mega Million Choices Lottery, and the winner of this year’s 50/50 PLUS.
Manitoba’s most exciting home lottery gave people an opportunity to make a life-saving difference at St. Boniface Hospital while gaining the chance to win life-changing prizes.
The winner of the Grand Prize is ticket number 2004989, belonging to Rose-Marie Beaulieu of Winnipeg, MB. As part of this year’s lottery, Beaulieu will choose from six Grand Prize options, including five spectacular $1.5 million home packages, or $1.25 million tax-free cash.
Watch the Grand Prize draw below!
The 50/50 PLUS totalling $1,449,300 was won by ticket number 3836400, belonging to Peter Lodewyks of Winnipeg, MB. Lodewyks will take home $724,650.
St. Boniface Hospital Foundation’s President and CEO, Karen Fowler, thanked lottery ticket buyers.
“Your generous support allows us to maintain funding for so many priorities here at St. B, such as medical research, cardiac care, palliative care, NICU, the Buhler Gallery, Volunteer Services, and more,” said Karen Fowler, President and CEO, St. Boniface Hospital Foundation. “These programs – and the people behind them – make St. B what it is: a community hospital that has grown to become the second largest tertiary care facility in Manitoba. One that is guided by the spirit of compassionate care that has infused the Hospital since its beginnings over 150 years ago.”
This year’s winners list will be published online at stbmegamillionchoices.ca. Video of the Grand Prize draw can also be viewed on Facebook: facebook.com/StBMegaMillionChoices.
Purpose, passion, progress … all possible thanks to lottery buyers
Every ticket purchased this year sent a strong message of hope to the healthcare heroes working at St. Boniface Hospital to take care of patients and their families. By supporting St. Boniface Hospital’s Mega Million Choices Lottery, ticket buyers have powered compassionate patient care and innovative medical research. Proceeds will fund vital capital expansions, leading-edge technology and medical equipment, and programs that support exceptional patient experiences.